Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication. - Wikidata - awgldk - TriplyDB

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.

http://www.wikidata.org/entity/Q37232717

about

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction Integrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma

P2860

Q57492406-4441F7F5-901A-4DE1-B9DC-21DAF115070B Q58733819-11B60028-7906-45BB-AE73-F1F525118365

P2860

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.

http://www.wikidata.org/entity/Q37232717

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pretreatment AKR1B10 expressio ...... hepatitis C virus eradication.

@en

Pretreatment AKR1B10 expressio ...... hepatitis C virus eradication.

@nl

type

label

Pretreatment AKR1B10 expressio ...... hepatitis C virus eradication.

@en

Pretreatment AKR1B10 expressio ...... hepatitis C virus eradication.

@nl

prefLabel

Pretreatment AKR1B10 expressio ...... hepatitis C virus eradication.

@en

Pretreatment AKR1B10 expressio ...... hepatitis C virus eradication.

@nl

P1433

Q37232717-FA568CC0-DFC7-493E-91E3-0BA9A07EB1CC

P1476

Q37232717-3D7B6C45-4AF3-41EA-8C75-944477EC7D77

P2093

Q37232717-05122362-10E0-4686-AC60-3BFAF023612F

Q37232717-111BB893-E355-4C67-8DD6-48F217EF3D1E

Q37232717-1BE0CB8A-49D0-403E-95E5-380EFFEE54FB

Q37232717-2BECC1B5-CCDF-4904-974E-8D100F27CE6E

Q37232717-38239B12-31D8-4F96-9225-101FF660B157

Q37232717-3F07EEE9-72F9-479C-AB34-08FDA71EB7D9

Q37232717-433257DA-41C3-4211-AC73-B984DB4EEB64

Q37232717-47E02401-F81A-437B-87B0-430B44D8FD0F

Q37232717-5C3932CC-F5F1-461A-85B8-AE50746DD467

Q37232717-63AE88B7-A6C8-4C5E-9D36-4214415D4A7D

P2860

Q37232717-012E9638-E413-449A-80EE-3A902447AB04

Q37232717-0E9692E5-2EBB-4F6D-B0C8-C7995CAFA863

Q37232717-15290CF6-E7F1-4BE2-BEED-3AF4B453B0EA

Q37232717-15F66BD6-3EBA-48B4-B840-3AABA6E9FCD1

Q37232717-1993C1EB-8A2D-4F85-8552-8603A941E654

Q37232717-1B33ED36-C5F0-445A-A72F-27444757FACF

Q37232717-1CC194BF-8DEF-4CAF-BF95-2A322CA348BE

Q37232717-29A54208-3775-4D65-B8BC-4B558B5106B4

Q37232717-2D6EE68F-9F8C-4328-A04F-04E2776E92FD

Q37232717-2FFC62BF-05AE-4351-8941-3974DA19E660

P304

Q37232717-9F619C80-A2D4-4786-80B1-CFC155127D86

P31

Q37232717-FAEE3072-1D26-4F4E-AFA8-6D2ED8754554

P356

Q37232717-89BFCEEC-3C2A-46E3-8ECD-F52E584829ED

P407

Q37232717-BA8AB1A2-CD0E-4485-B319-F4CB569582CD

P433

Q37232717-5B767204-0F0D-428C-A83E-EA90DA0917EC

P478

Q37232717-9E0F9960-DD01-4580-80E8-C3590D284C0E

P577

Q37232717-7A3F46A1-6628-4CA4-AE03-181CF449E7C2

P698

Q37232717-8D1D1530-A70B-4BE0-A8F7-7750BB4AD612

P921

Q37232717-3DF48208-2943-4E87-91F8-DD09BFFB7BBA

P932

Q37232717-48547263-FE1E-47BB-AAF4-A8E380D8E980

P356

WJG.V22.I33.7569

P1433

World Journal of Gastroenterology

P1476

Pretreatment AKR1B10 expressio ...... hepatitis C virus eradication.

@en

P2093

Akihito Nagahara

http://www.w3.org/2001/XMLSchema#string

Ayato Murata

http://www.w3.org/2001/XMLSchema#string

Hironori Tsuzura

http://www.w3.org/2001/XMLSchema#string

Katsuharu Hirano

http://www.w3.org/2001/XMLSchema#string

Katsuyori Iijima

http://www.w3.org/2001/XMLSchema#string

Nozomi Amano

http://www.w3.org/2001/XMLSchema#string

Ryo Wada

http://www.w3.org/2001/XMLSchema#string

Sho Sato

http://www.w3.org/2001/XMLSchema#string

Shunsuke Sato

http://www.w3.org/2001/XMLSchema#string

Sumio Watanabe

http://www.w3.org/2001/XMLSchema#string

P2860

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

Identification and characterization of a novel human aldose reductase-like gene

Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism

Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis

Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis

P304

7569-7578

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V22.I33.7569

http://www.w3.org/2001/XMLSchema#string

P407

P433

33

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27672277

http://www.w3.org/2001/XMLSchema#string

P921

eradication of infectious diseases

P932

5011670

http://www.w3.org/2001/XMLSchema#string